T. Farrah, E.W. Deutsch, G.S. Omenn, D.S. Campbell, Z. Sun, J.A. Bletz, P. Mallick, J.E. Katz, J. Malmstrom, R. Ossola, J.D. Watts, B. Lin, H. Zhang, R.L. Moritz and R.H. Aebersold (2011). A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics. First Published on June 1, 2011.
N. Shah, B. Lin, Z. Sibenaller, T. Ryken, H. Lee, J-G. Yoon, S. Rostad, G. Foltz (2011) Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM. PLoS ONE 6(1): e16146
X. Fang, J.-G. Yoon, L. Li, W. Yu, J. Shao, D. Hua, S. Zheng, L. Hood, D. R Goodlett, G. Foltz, B. Lin (2011) The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics 12:11.
L. Ma, C. Zhou, B. Lin & W. Li (2010) A porous 3D cell culture micro device for cell migration study. Biomed Microdevices 12:753–760
J.W. Henson & B.P. Keogh (2010) Assessing Radiographic Response to Bevacizumab in Patients with GBM. Published in Controversies in Neuro-Oncology Vol. 1, Thomas C. Chen, Ed.
X. Fang, J-G Yoon, L. Li, Y. Tsai S. Zheng, L. Hood, D. Goodlett, G. Foltz & B. Lin (2010) Landscape of the SOX2 protein–protein interactome. Proteomics 11:921–934
K.M. Panchalingam, W.J. Paramchuk, C.Y. Chiang, N. Shah, A. Madan, L. Hood, G. Foltz, L.A. Behie (2010) Bioprocessing of human glioblastoma brain cancer tissue. Tissue Eng Part A 16:1169-77.
Lin, B.; Madan, A.; Yoon, J. G.; Fang, X.; Yan, X.; Kim, T. K.; Hwang, D.; Hood, L.; Foltz, G. (2010) Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS One 5 (4), e10210.
Foltz, G.; Yoon, J. G.; Lee, H.; Ryken, T. C.; Sibenaller, Z.; Ehrich, M.; Hood, L.; Madan, A. (2009) DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis. Oncogene 28:2667-77.
Vibhakar, R.; Foltz, G.; Yoon, J. G.; Field, L.; Lee, H.; Ryu, G. Y.; Pierson, J.; Davidson, B.; Madan, A. (2007) Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. Neuro. Oncol. 9:135-44
Foltz, G.; Ryu, G. Y.; Yoon, J. G.; Nelson, T.; Fahey, J.; Frakes, A.; Lee, H.; Field, L.; Zander, K.; Sibenaller, Z.; Ryken, T. C.; Vibhakar, R.; Hood, L.; Madan, A. (2006) Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Research, 66:6665-74
D. Spencer, R. Gwinn, M. Salinsky, JP O'Malley (2011) Laterality and temporal distribution of seizures in patients with bitemporal independent seizures during a trial of responsive neurostimulation. Epilepsy Research 93:221-5
Doherty, M., Grieff, A., Kovach K. and Haltiner, A. (2010) Are some objects in Wada testing easier to remember than others? 2010 American Epilepsy Society Conference, Abstract 1.342
Doherty M.J., Sloan D (2010) Tourette syndrome and epilepsy: a strange case of possible sudden unexpected death. Epilepsy Behav. 17:285-6.
Doherty MJ, Youn CE, Haltiner AM, Watson NF. (2010) Do weather-related ambient atmospheric-pressure changes influence sleep disordered breathing? J Clin Sleep Med. 6:152-6.
P. Repovic, F.D. Lublin (2011) Treatment of multiple sclerosis exacerbations. Neurologic Clinics, 29(2):389-400
Mayadev A., Kraft G.H. (2011) Cerebellar and Brainstem Dysfunction in Multiple Sclerosis. In: Giesser, B. Primer on Multiple Sclerosis. 13: 179-188.
Bowen JD, Wingerchuk DM, Wundes A, Kraft GH, McLaughlin BA, Henstorf G, Nash RA. (2009) Treatment of aggressive neuromyelitis optica with high-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation. ACTRIMS Conference.
Hutton G, Bowen J, Forman S, Frohman E, Griffigh L, Kraft G, Muraro P, Openshaw H, Popat U, Racke M, Sayre P, Stuve O, Wundes A, Nash R. (2009) HALT-MS – Intense immunosuppression and stem cell transplantation for relapsing-remitting multiple sclerosis. CMSC 2009.
Dublin S, Anderson ML, Heckbert SR, Haneuse SJ, Crane PK, Breitner JC, McCormick W, Bowen JD, Teri L, McCurry SM, Larson EB. Atrial fibrillation and risk of incident dementia or Alzheimer's disease. Poster presentation, Presidential Poster Session. American Geriatrics Society 2010 Annual Meeting, Orlando, FL, May 12-15, 2010.
Yadav V, Bourdette D, Bowen JD, Lynch SG, Mattson D, Preiningerova J, Rose C, Stead RB, Ferro AJ, Goldstein AS, Burrows G, Offner H, Arthur Vandenbark, A. Recombinant T Cell Receptor Ligand (RTL) for the Treatment of Multiple Sclerosis: Report of a Phase I Clinical Trial. Neurology 2010;74:A293-4.
Lavy LV, Bamer A, Bowen JD, Kraft GH. Attitudes about physician-assisted suicide in patients with multiple sclerosis. Neurology 2010;74:A159.
Polman C, Bowen JD, Barkhof F, Bates D, Wynn D, Sanders EACM, Wolf C, Morris T, Duda P, Weinkauf B, Bennett B. Double-blind, placebo-controlled randomized phase II serial MRI, safety and tolerability study of two doses of CDP323 in subjects with relapsing forms of multiple sclerosis over 24 weeks. Neurology 2010;74:A293.
Jung LK, Mayadev AS, Bowen JD, Tomas EM (submitted) Incidence of Infections in Multiple Sclerosis Patients Receiving Natalizumab Versus Other Disease-Modifying Treatments. Abstract submitted to PACTRIMS 2010 Conference.
A. Mayadev, J. Jesurum, K. Kobata, C. Frederiksen, E. Tomas, T. Hayward, L. Jung (2010) Beneficial effects of an exercise wellness programme on functional and quality of life outcomes in patients with multiple sclerosis: an interim analysis. Presented at the 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in MS (RIMS).
M.J. Winder and M.R. Mayberg (2011) Recent advances in pituitary tumor management. Current Opinion in Endocrinology, Diabetes & Obesity, 18(4):278–288.
W.H. Ludlam, J.U. Mercado, K.J. Moloney, M.R. Mayberg (2011) Fully Suppressed Post-Operative Serum Cortisol Level in a Cushing’s Disease Patient Despite Incomplete Surgical Removal of a Pituitary Macroadenoma. Presented at American Association of Clinical Endocrinologists (AACE) meeting, San Diego, CA, USA, April, 2011.
W.H. Ludlam, J.U. Mercado, K.J. Moloney, M.R. Mayberg (2011) Diagnosis of Cushing’s Disease in a Patient With Consistently Normal Urinary Free Cortisol Levels: A Case Report. Presented at American Association of Clinical Endocrinologists (AACE) meeting, San Diego, CA, USA, April, 2011.
Eboli P, Shafa B, Mayberg MR. Intraoperative CT registration and electromagnetic neuronavigation for transsphenoidal pituitary surgery: accuracy and time-effectiveness. JNS, in press, 2010.
J. Hsiang (2011) Preservation of the midline structures in one-level lumbar decompression and fusion surgery. Description of a new technique and assessment of efficacy and complication in 40 patients. Presentation to the American College of Spine Surgery Annual Conference. June 3-5, 2011, Las Vegas, NV.
J. Hsiang (2011) Wrong-level surgery: A unique problem in spine surgery. Surg Neurol Int, 47
Floman JE, Baldwin NG, Hsiang J, Webb S, Youssef JA, Rughani A. (2010) Two-year clinical and radiographic follow-up after cervical intervertebral arthroplasty: Preliminary Data. Poster Presentation, 2010 CNS Annual Meeting, San Francisco.
Kim KD, Wright NM, Mayberg MR (2010) Polythylene Glycol (PEG) Hydrogel Spinal Sealant (DuraSeal™ Spinal Sealant) as an Adjunct to Sutured Dural Repair in the Spine: Results of a Prospective, Multicenter, Randomized Controlled Study. Spine, submitted.
Hsiang, J. (2009) Spinal Stenosis. eMedicine: July 30, 2009
Dana Leifer, Dawn M. Bravata, J.J. (Buddy) Connors III, Judith A. Hinchey, Edward C. Jauch, S. Claiborne Johnston, Richard Latchaw, William Likosky, Christopher Ogilvy, Adnan I. Qureshi, Debbie Summers, Gene Y. Sung, Linda S. Williams and Richard Zorowitz. Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations : A Statement for Healthcare Professionals From the American Heart Association/American Stoke Association. Stroke. 2011;42:849-877; originally published online January 13, 2011; doi: 10.1161/STR.0b013e318208eb99
A. Malik, N.A. Vora, R. Lin, S.F. Zaidi, A. Aleu, B.T. Jankowitz, M.A. Jumaa, V.K. Reddy, M.D. Hammer, L.R. Wechsler, M.B. Horowitz, T.G. Jovin. Facilitated Recanalization in Endovascular Treatment of Extracranial/Intracranial Tandem Occlusions. Abstract presented at 2011 International Stroke Conference Annual Meeting, Los Angeles, CA.
A.M. Malik, N.A. Vora, R. Lin, S.F. Zaidi, A. Aleu, B.T. Jankowitz, M.A. Jumaa, V.K. Reddy, M.D. Hammer, L.R. Wechsler, M.B. Horowitz and T.G. Jovin (2011) Endovascular Treatment of Tandem Extracranial/Intracranial Anterior Circulation Occlusions: Preliminary Single-Center Experience. Stroke 42(6):1653-7.
Schwamm LH, Holloway RG, Audebert P, Bakas T, Chumbler NR, Handschu R , Jauch EC, Knight WA, Levine SR, Mayberg MR, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR. A Review of the Evidence for the Use of Telemedicine within Stroke Systems of Care - A Scientific Statement from the American Heart Association. Stroke 2009;40:2616-2634..
Wang G, Guo Q, Hossain M, Faziov V, Zeynalov E, Janigro D, Mayberg MR, Namura S. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Research. Oct. 19, 2009; 1294: 183-92. Epub Jul 2009.
Lipson AC, Foltz G, West, AG, Newell DW, Britz GW. Late de novo basilar aneurysm following carotid injury. Journal of Neurosurgery, 2008 Mar;108(3):607
Srivi GE, Zaaroor M, Britz GW, Douville CM, Lam A, Newell DW. Basilar artery vasospasm: diagnosis and grading by transcranial Doppler. In Cerebral Vasospasm New Strategies in Research and Treatment, Vasospasm Diagnostic. Springer – Verlag / Wien, New York, 2008. pp. 255-257
Brisman JL, Newell DW, Eskridge JM. Endovascular Treatment of post-subarachnoid hemorrhage vasospasm. In Interventional Neuroradiology. Chapter 14 pp 263-273 2008
Brisman JL, Eskridge JM, Newell DW. Neurointerventional treatment of vasospasm. In Neurological Research, 2006, 28 (7), pp. 769-76
Sviri, GE, Aaslid R, Douville CM, Moore A, Newell DW. Time course for autoregulation recovery following severe traumatic brain injury. Journal of Neurosurgery. 111:695–700, 2009
Newell DW, Brits GW, Brisman J. Cerebral vascularization. Neurosurgical Focus, 2008. 24 (2) pp. E1
Vilela MD, Newell DW. Superficial temporal artery to middle cerebral artery bypass: past, present, and future. Neurosurgical Focus. 2008. 24 (2) pp. E2
Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurgical Focus. 24 (2),2008 pp. E15
Sviri GE, Zaaroor M, Britz GW, Douville CM, Lam A, Newell DW Basilar Artery Vasospasm: diagnosis and grading by Trancranial Doppler Cerebral Vasospasm Vol 104 Part 8 pp 255-257 Springer Vienna 2008
Bellabara C, Mirza SK, West GA, Mann FA, Newell DW, Chapman JR, Diagnosis and Treatment of Craniocervical Dissociation. One institution’s Experience with Seventeen Consecutive Survivors over Seven Years. British Journal of Bone and Joint Surgery v90-B Issue Supp I, 71 2008
Sviri GE, Zaaroor M, Britz GW, Douville CM, Lam A, Newell DW Basilar artery vasospasm: impact on outcome Cerebral Vasospasm Vol 104 Part 12 pp 387-389 Springer Vienna 2008
Newell DW, Vilela MD (2009) Extracranial To Intracranial Bypass For Cerebral Ischemia
V.L. Yarnykh, J.D. Bowen, B.P. Keogh, P. Repovic, B. Gangadharan, D.S. Rizzuto, H.R. Underhill, K.R. Maravilla, and L.K. Jung-Henson. Fast Macromolecular Proton Fraction (MPF) mapping in multiple sclerosis. 136th American Neurological Association Annual Meeting. September 25 - 27, 2011. San Diego, CA
Billings, M., Keogh, B.P., Watson, N.F. (2011) Dynamic fMRI Changes in Kleine-Levin Syndrome. Sleep Medicine, 12(5):532.
Neuroscience Institute Administrative Office550 17th Avenue
Seattle, WA 98122
8 a.m. - 4:30 p.m.
Map & Directions
Need a second opinion?
How you can help
Swedish is constantly working to ensure patients with debilitating neurological disorders have access to the best treatment options, the latest technology, and state-of-the-art facilities.
What to expect during your hospital stay
Take a personalized interactive tour, click here.